Keywords: dyax, completes, bla, dx-88, hae, massachusetts, usa-headquartered

Dyax completes BLA for DX-88 in HAE

Article | 29 September 2008

Massachusetts, USA-headquartered Dyax Corp has announced the completion of its Biologics License Application with the Food and Drug Administration for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing